Skip to main content
Caplight Logo









Minomic International

Minomic International

Private
SydneyHealthcare & Life Scienceshttps://minomic.com/

Last Round

Grant

Feb 2, 2022

Total Funding Raised

$1.09M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Minomic International is a biotechnology company that develops non-invasive diagnostic tests for cancer, including its flagship MiCheck® Prostate test for the risk assessment of clinically significant prostate cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

prostate cancer diagnosticblood-based diagnosticliquid biopsycancer biomarkerprostate cancer screeningmonoclonal antibodyclinical decision supportprecision oncologydiagnostic algorithmprostate-specific antigenPSACLIA labcancer imagingbiotech diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Minomic International Comparables

Compare Minomic International with similar companies based on industry and business-model similarity.

Minomic International comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LynxDx
84%
A3P Biomedical
83%
NucleoBio Corp
82%

Minomic International Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 2, 2022
GrantNov 1, 2015
VC RoundMar 8, 2012

Minomic International Investors

Notable investors and investment history

Minomic International investors
InvestorRounds
National Health and Medical Research CouncilGrant
Australian Research CouncilGrant
AMGCGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 14, 2026

    Monthly visitors grew 169% MoM, reaching 2K.

  • Apr 18, 2026

    Monthly visitors grew 542% MoM, from 114 to 732.

Minomic International Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Minomic International Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Minomic International's valuation, stock price, and market status.

Firmographic Details

HeadquartersSydney
Employee Range13
Year Founded2000
Last FundingFeb 2, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?